SLN

#2809
Silence Therapeutics Plc - American Depository Share
6.9 0 USD
+0.44%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
6.90
6.90
Rango anual
4.19
8.40
Cambio diario
+0.44%
Variación mensual
-4.43%
Variación en los últimos 6 meses
+4.07%
Cambio anual
+14.24%
Cierres anteriores
6.8 7
Open
6.9 0
Mínimo
6.9 0
High
6.9 0
Volumen
29
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 325.92 M
  • Employee 88
  • Founded 1994
  • CEO Craig A Tooman
  • Website www.silence-therapeutics.com
  • Headquarter United Kingdom
  • FIGI BBG00WVTHPN2
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.65
Relación precio/flujo de caja
1 541.15

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Noticias